New Jersey's most recent revised policy was issued September 7, 2022 pursuant to P.L.2021, c.152 which authorized opioid antidotes to be dispensed without a prescription or fee. [2] Its goal is to make opioid antidotes widely available, reducing mortality from overdose while decreasing morbidity in conjunction with sterile needle access, fentanyl test strips, [3] and substance use treatment programs. [4] A $67 million grant provided by the Department of Health and Human Services provides funding for naloxone as well as recovery services. [5] This policy enables any person to distribute an opioid antidote to someone they deem at risk of an opioid overdose, alongside information regarding: opioid overdose prevention and recognition, the administration of naloxone, circumstances that warrant calling 911 for assistance with an opioid overdose, and contraindications of naloxone. Instructions on how to perform resuscitation and the appropriate care of an overdose victim after the administration of an opioid antidote should also be included. [2] Community first aid squads, professional organizations, police departments, and emergency departments are required to "leave-behind" naloxone and information with every person who overdosed or is at risk of overdosing. [4]
The opioid epidemic in the United States occurred in 3 waves: [6]
NJ overdose deaths peaked in 2020 [8] influenced by the COVID-19 pandemic. [9] In 2020, the overdose death rate was 32.1 per 100,000 statewide but varies widely by county. [10]
There were 40,893 admissions to NJ heroin abuse treatment programs in 2019, dropping to 33,030 in 2020. Admissions have not reached 2019 levels as of 2021. [11]
Rates of hospital admissions from non-fatal opioid overdoses peaked in 2018, and steadily declined until 2021. [12]
The "Overdose Prevention Act" passed in 2013 focused on reducing fear or delay in initiating emergency medical response by providing immunity from arrest or prosecution for simple possession when a person seeks help for themself or another.
In 2017, Governor Chris Christie passed a non-partisan bill limiting all first-time opioid prescriptions to five days, and mandating that all health plans provide 6 months of SUD treatment and 28 days of inpatient care. This means health insurance providers must treat addiction like a disease, reducing wait times and the need for pre-authorization. Additionally, it outlined new education for opioid prescribers. [13] [14]
In 2020, a bill sponsored by Senator Vin Gopal amended P.L 2017 c.28, requiring naloxone to be co-prescribed in certain circumstances, such as:
Later, public health officials shifted their focus to harm reduction, and in 2021 Governor Murphy passed 3 bills that promoted distribution of sterile needles, decriminalized possession of a syringe, and established local overdose review teams. [16]
New Jersey has fully integrated emergency medical services into the Overdose Mapping and Application program provided by New Jersey State Police, making it the first state with 100% overdose data integration between EMS organizations and police. It also created the Five Minutes to Help curriculum that trains all emergency responders in deploying naloxone. [17]
In March 2023, Governor Phil Murphy established the Opioid Recovery and Remediation Fund, which will divide over $600 million from settlements with pharmaceutical companies and pharmacy chains among the state's municipalities. [18] This bill follows Executive Order No. 305, which first established how opioid settlement funds would be used.
Heroin, also known as diacetylmorphine and diamorphine among other names, is a morphinan opioid substance derived from the dried latex of the Papaver somniferum plant and is mainly used as a recreational drug for its euphoric effects. Medical-grade diamorphine is used as a pure hydrochloride salt. Various white and brown powders sold illegally around the world as heroin are routinely diluted with cutting agents. Black tar heroin is a variable admixture of morphine derivatives—predominantly 6-MAM (6-monoacetylmorphine), which is the result of crude acetylation during clandestine production of street heroin. Heroin is used medically in several countries to relieve pain, such as during childbirth or a heart attack, as well as in opioid replacement therapy.
Harm reduction, or harm minimization, refers to a range of intentional practices and public health policies designed to lessen the negative social and/or physical consequences associated with various human behaviors, both legal and illegal. Harm reduction is used to decrease negative consequences of recreational drug use and sexual activity without requiring abstinence, recognizing that those unable or unwilling to stop can still make positive change to protect themselves and others.
Fentanyl, also spelled fentanil, is a highly potent synthetic piperidine opioid drug primarily used as an analgesic. Because fentanyl is 50 to 100 times more potent than morphine, its primary clinical utility is in pain management for cancer patients and those recovering from painful surgical operations. Fentanyl is also used as a sedative. Depending on the method of delivery, fentanyl can be very fast acting and ingesting a relatively small quantity can cause overdose. Fentanyl works by activating mu-opioid receptors. Fentanyl is also commonly known as fentanyl citrate, and is sold under the brand name Sublimaze among others.
Naloxone, is a medication used to reverse or reduce the effects of opioids sold under various brands. It is used to counter decreased breathing in opioid overdose. Effects begin within two minutes when given intravenously, and within five minutes when injected into a muscle. The medicine can also be administered by spraying it into a person's nose. Naloxone blocks the effects of opioids for 30 to 90 minutes. Multiple doses may be required, as the duration of action of some opioids is greater than that of naloxone. Emergency medical services data from Massachusetts found that 93.5% of people given naloxone survived their overdose.
A drug overdose is the ingestion or application of a drug or other substance in quantities much greater than are recommended. Typically it is used for cases when a risk to health will potentially result. An overdose may result in a toxic state or death.
Opioid use disorder (OUD) is a substance use disorder characterized by cravings for opioids, continued use despite physical and/or psychological deterioration, increased tolerance with use, and withdrawal symptoms after discontinuing opioids. Opioid withdrawal symptoms include nausea, muscle aches, diarrhea, trouble sleeping, agitation, and a low mood. Addiction and dependence are important components of opioid use disorder.
Xylazine is a drug used for sedation, anesthesia, muscle relaxation, and analgesia in animals such as horses, cattle, and other non-human mammals. It is an analog of clonidine and an agonist at the α2 class of adrenergic receptor.
Walter Reed Gusciora is an American Democratic Party politician who has served as the mayor of Trenton, New Jersey since 2018. He previously served from 1996 to 2018 in the New Jersey General Assembly, where he represented the 15th Legislative District.
An opioid overdose is toxicity due to excessive consumption of opioids, such as morphine, codeine, heroin, fentanyl, tramadol, and methadone. This preventable pathology can be fatal if it leads to respiratory depression, a lethal condition that can cause hypoxia from slow and shallow breathing. Other symptoms include small pupils, and unconsciousness, however its onset can depend on the method of ingestion, the dosage and individual risk factors. Although there were over 110,000 deaths in 2017 due to opioids, individuals who survived also faced adverse complications, including permanent brain damage.
Acetylfentanyl is an opioid analgesic drug that is an analog of fentanyl. Studies have estimated acetylfentanyl to be fifteen times more potent than morphine, which would mean that despite being somewhat weaker than fentanyl, it is nevertheless still several times stronger than pure heroin. It has never been licensed for medical use and instead has only been sold as a designer drug. Acetylfentanyl was discovered at the same time as fentanyl itself and had only rarely been encountered on the illicit market in the late 1980s. However, in 2013, Canadian police seized 3 kilograms of acetylfentanyl. As a μ-opioid receptor agonist, acetylfentanyl may serve as a direct substitute for heroin or other opioids. Common side effects of fentanyl analogs are similar to those of fentanyl itself, which include itching, nausea and potentially serious respiratory depression, which can be life-threatening. Fentanyl analogs have killed hundreds of people throughout Europe and the former Soviet republics since the most recent resurgence in use began in Estonia in the early 2000s, and novel derivatives continue to appear.
Buprenorphine/naloxone, sold under the brand name Suboxone among others, is a fixed-dose combination medication that includes buprenorphine and naloxone. It is used to treat opioid use disorder, and reduces the mortality of opioid use disorder by 50%. It relieves cravings to use and withdrawal symptoms. Buprenorphine/naloxone is available for use in two different forms, under the tongue or in the cheek.
The Pennsylvania Department of Drug and Alcohol Programs is a cabinet-level agency in the Government of Pennsylvania. The objective of this department is to manage and distribute state and federal funds used to oversee alcohol and drug prevention, intervention and treatment services.
Jack Fishman, born Jacob Fiszman, was a Jewish-American pharmaceutical researcher from Kraków, Poland. In 1961, along with Mozes J. Lewenstein, he developed the medication naloxone, which can reverse an opioid overdose, and the Centers for Disease Control and Prevention has described as a "a life-saving medication that can reverse an overdose from opioids—including heroin, fentanyl, and prescription opioid medications."
In the United States, the opioid epidemic is an extensive ongoing overuse of opioid medications, both from medical prescriptions and illegal sources. The epidemic began in the United States in the late 1990s, according to the Centers for Disease Control and Prevention (CDC), when opioids were increasingly prescribed for pain management, resulting in a rise in overall opioid use throughout subsequent years. The great majority of Americans who use prescription opioids do not believe that they are misusing them.
A take-home naloxone program is a governmental program that provides naloxone drug kits to those that are at risk of an opioid overdose. Naloxone is a medication that was created to reverse opioid overdoses. As an opioid antagonist, it binds to the μ-opioid receptors blocking the opioid's effects. Naloxone quickly restores normal respiration. The ongoing opioid epidemic has caused many public health authorities to expand access to naloxone.
The opioid epidemic, also referred to as the opioid crisis, is the rapid increase in the overuse, misuse/abuse, and overdose deaths attributed either in part or in whole to the class of drugs called opiates/opioids since the 1990s. It includes the significant medical, social, psychological, demographic and economic consequences of the medical, non-medical, and recreational abuse of these medications.
Shereef Elnahal is an American physician who is the current United States Under Secretary of Veterans Affairs for Health. He previously served as the 21st commissioner of the New Jersey Department of Health from 2018 to 2019, and as the president/CEO of University Hospital in Newark from 2019 to 2022. He also previously served as an Assistant Deputy Under Secretary for Health for Quality, Safety and Value from 2016-2018
Harm reduction consists of a series of strategies aimed at reducing the negative impacts of drug use on users. It has been described as an alternative to the U.S.'s moral model and disease model of drug use and addiction. While the moral model treats drug use as a morally wrong action and the disease model treats it as a biological or genetic disease needing medical intervention, harm reduction takes a public health approach with a basis in pragmatism. Harm reduction provides an alternative to complete abstinence as a method for preventing and mitigating the negative consequences of drug use and addiction.
In response to the surging opioid prescription rates by health care providers that contributed to the opioid epidemic in the United States, US states began passing legislation to stifle high-risk prescribing practices. These new laws fell primarily into one of the following four categories:
Access, Harm Reduction, Overdose Prevention and Education, commonly referred to as AHOPE Boston or AHOPE Needle Exchange, and formerly called Addicts Health Opportunity Prevention Education, is a needle exchange and public health initiative of the Boston Public Health Commission.